View in EDS PDF Full Text

[The Prognosis Assessment Value of Interim 18F-FDG PET/CT Imaging in the Chemotherapy of Diffuse Large B-cell Lymphoma].

Saved in:
Bibliographic Details
Title: [The Prognosis Assessment Value of Interim 18F-FDG PET/CT Imaging in the Chemotherapy of Diffuse Large B-cell Lymphoma].
Authors: Peng XJ; Department of Nuclear Medicine, Affiliated Hospital of North Sichuan Medical College, Nanchong 637007, Sichuan Province, China; PET/CT Center, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, Sichuan Province, China., Kou Y; PET/CT Center, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, Sichuan Province, China., Yu SS; Department of Medical Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, Sichuan Province, China., Yao YT; PET/CT Center, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, Sichuan Province, China., Jiang XM; Department of Nuclear Medicine, Affiliated Hospital of North Sichuan Medical College, Nanchong 637007, Sichuan Province, China; PET/CT Center, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, Sichuan Province, China., You JH; Department of Nuclear Medicine, Affiliated Hospital of North Sichuan Medical College, Nanchong 637007, Sichuan Province, China., Zhang ZH; Department of Medical Oncology, Sichuan Cancer Hospital ＆ Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, Sichuan Province, China., Chen SR; PET/CT Center, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, Sichuan Province, China., Jiang X; PET/CT Center, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, Sichuan Province, China; Institute of Isotopes, China Institute of Atomic Energy, Beijing 102413, China., Cheng ZZ; Department of Nuclear Medicine, Affiliated Hospital of North Sichuan Medical College, Nanchong 637007, Sichuan Province, China; PET/CT Center, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, Sichuan Province, China. E-mail: chengzhuzhong@163.com.
Source: Zhongguo shi yan xue ye xue za zhi [Zhongguo Shi Yan Xue Ye Xue Za Zhi] 2022 Oct; Vol. 30 (5), pp. 1440-1445.
Publication Type: Journal Article
Journal Info: Publisher: Zhongguo shi yan xue za zhi she Country of Publication: China NLM ID: 101084424 Publication Model: Print Cited Medium: Print ISSN: 1009-2137 (Print) Linking ISSN: 10092137 NLM ISO Abbreviation: Zhongguo Shi Yan Xue Ye Xue Za Zhi Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36208247
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: [The Prognosis Assessment Value of Interim <superscript>18</superscript>F-FDG PET/CT Imaging in the Chemotherapy of Diffuse Large B-cell Lymphoma].
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Peng+XJ%22">Peng XJ</searchLink>; Department of Nuclear Medicine, Affiliated Hospital of North Sichuan Medical College, Nanchong 637007, Sichuan Province, China; PET/CT Center, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, Sichuan Province, China.<br /><searchLink fieldCode="AU" term="%22Kou+Y%22">Kou Y</searchLink>; PET/CT Center, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, Sichuan Province, China.<br /><searchLink fieldCode="AU" term="%22Yu+SS%22">Yu SS</searchLink>; Department of Medical Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, Sichuan Province, China.<br /><searchLink fieldCode="AU" term="%22Yao+YT%22">Yao YT</searchLink>; PET/CT Center, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, Sichuan Province, China.<br /><searchLink fieldCode="AU" term="%22Jiang+XM%22">Jiang XM</searchLink>; Department of Nuclear Medicine, Affiliated Hospital of North Sichuan Medical College, Nanchong 637007, Sichuan Province, China; PET/CT Center, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, Sichuan Province, China.<br /><searchLink fieldCode="AU" term="%22You+JH%22">You JH</searchLink>; Department of Nuclear Medicine, Affiliated Hospital of North Sichuan Medical College, Nanchong 637007, Sichuan Province, China.<br /><searchLink fieldCode="AU" term="%22Zhang+ZH%22">Zhang ZH</searchLink>; Department of Medical Oncology, Sichuan Cancer Hospital ＆ Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, Sichuan Province, China.<br /><searchLink fieldCode="AU" term="%22Chen+SR%22">Chen SR</searchLink>; PET/CT Center, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, Sichuan Province, China.<br /><searchLink fieldCode="AU" term="%22Jiang+X%22">Jiang X</searchLink>; PET/CT Center, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, Sichuan Province, China; Institute of Isotopes, China Institute of Atomic Energy, Beijing 102413, China.<br /><searchLink fieldCode="AU" term="%22Cheng+ZZ%22">Cheng ZZ</searchLink>; Department of Nuclear Medicine, Affiliated Hospital of North Sichuan Medical College, Nanchong 637007, Sichuan Province, China; PET/CT Center, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, Sichuan Province, China. E-mail: chengzhuzhong@163.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101084424%22">Zhongguo shi yan xue ye xue za zhi</searchLink> [Zhongguo Shi Yan Xue Ye Xue Za Zhi] 2022 Oct; Vol. 30 (5), pp. 1440-1445.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Zhongguo+shi+yan+xue+za+zhi+she%22">Zhongguo shi yan xue za zhi she </searchLink><i>Country of Publication: </i>China <i>NLM ID: </i>101084424 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>1009-2137 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210092137%22">10092137 </searchLink><i>NLM ISO Abbreviation: </i>Zhongguo Shi Yan Xue Ye Xue Za Zhi <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36208247
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.19746/j.cnki.issn.1009-2137.2022.05.021
    Languages:
      – Code: chi
        Text: Chinese
    PhysicalDescription:
      Pagination:
        StartPage: 1440
    Titles:
      – TitleFull: [The Prognosis Assessment Value of Interim 18F-FDG PET/CT Imaging in the Chemotherapy of Diffuse Large B-cell Lymphoma].
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Peng XJ
      – PersonEntity:
          Name:
            NameFull: Kou Y
      – PersonEntity:
          Name:
            NameFull: Yu SS
      – PersonEntity:
          Name:
            NameFull: Yao YT
      – PersonEntity:
          Name:
            NameFull: Jiang XM
      – PersonEntity:
          Name:
            NameFull: You JH
      – PersonEntity:
          Name:
            NameFull: Zhang ZH
      – PersonEntity:
          Name:
            NameFull: Chen SR
      – PersonEntity:
          Name:
            NameFull: Jiang X
      – PersonEntity:
          Name:
            NameFull: Cheng ZZ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2022 Oct
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 1009-2137
          Numbering:
            – Type: volume
              Value: 30
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Zhongguo shi yan xue ye xue za zhi
              Type: main
ResultId 1